Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $26.48 USD
Change Today +0.17 / 0.65%
Volume 0.0
STERLINBIO On Other Exchanges
STERLINBIO is not on other exchanges.
As of 9:29 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

sterling biotech ltd (STERLINBIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/15 - $27.14
52 Week Low
10/13/14 - $23.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sterling biotech ltd (STERLINBIO) Related Businessweek News

No Related Businessweek News Found

sterling biotech ltd (STERLINBIO) Details

Sterling Biotech Limited engages in the manufacture and sale of pharmaceutical grade gelatine and di-calcium phosphate, and other pharmaceutical products in India. The company’s products include Co-enzyme Q10, a dietary supplement that enhances memory and exercise performance, and boosts immunity and energy; DOXO Rubicin, Daunorubicin, EPI Rubicin, IMATINIB, Idarubicin, and Dacarbazine for oncology; Lovastatin for cardiovascular therapeutic area; and Temozolamide for the treatment of Grade IV astrocytoma. It also has products under development stage for various therapeutic areas comprising oncology, anti-hypertensive, anti-hyperlipidemic, CNS, anti-psychotic, immunosuppressants, renal failure, antibiotic, anti-fungal, and anti-diabetics. Sterling Biotech Limited was incorporated in 1985 and is based in Mumbai, India.

Founded in 1985

sterling biotech ltd (STERLINBIO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sterling biotech ltd (STERLINBIO) Key Developments

Sterling Biotech Ltd Announces Demise of N. B. Patel, Director of the Company

Sterling Biotech Ltd. has announced the sad demise of Shri N. B. Patel, Director of the Company.

Sterling Biotech Limited to Report Fiscal Year 2014 Results on Feb 28, 2015

Sterling Biotech Limited announced that they will report fiscal year 2014 results on Feb 28, 2015

Sterling Biotech Limited, Board Meeting, Feb 28, 2015

Sterling Biotech Limited, Board Meeting, Feb 28, 2015. Agenda: To consider audited accounts for the year ended on December 31, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLT:IN 4.55 INR -0.35

STERLINBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STERLINBIO.
View Industry Companies

Industry Analysis


Industry Average

Valuation STERLINBIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STERLING BIOTECH LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at